ETF Managers Group, LLC Agios Pharmaceuticals, Inc. Transaction History

ETF Managers Group, LLC

$2.78 Billion
Q1 2023

A detailed history of ETF Managers Group, LLC transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, ETF Managers Group, LLC holds 24,797 shares of AGIO stock, worth $847,809. This represents 0.02% of its overall portfolio holdings.

Number of Shares

24,797

Previous 24,427 1.51%

Holding current value

$847,809

Previous $685,000 16.93%

% of portfolio

0.02%

Previous 0.03%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 17, 2023	BUY	$21.74 - $30.93 $8,043 - $11,444	370 Added 1.51%	24,797 $569,000
Q4 2022 Mar 23, 2023	BUY	$24.81 - $31.52 $22,080 - $28,052	890 Added 3.78%	24,427 $685,000
Q3 2022 Nov 14, 2022	BUY	$19.51 - $34.14 $17,773 - $31,101	911 Added 4.03%	23,537 $666,000
Q2 2022 Aug 15, 2022	BUY	$17.06 - $31.42 $156,406 - $288,058	9,168 Added 68.12%	22,626 $506,000
Q1 2022 May 13, 2022	BUY	$26.68 - $34.81 $6,003 - $7,832	225 Added 1.7%	13,458 $395,000
Q4 2021 Feb 14, 2022	BUY	$29.58 - $49.78 $18,635 - $31,361	630 Added 5.0%	13,233 $444,000
Q3 2021 Nov 15, 2021	BUY	$41.92 - $58.18 $40,620 - $56,376	969 Added 8.33%	12,603 $582,000
Q2 2021 Aug 16, 2021	BUY	$52.06 - $61.27 $134,262 - $158,015	2,579 Added 28.48%	11,634 $623,000
Q1 2021 May 17, 2021	BUY	$44.23 - $57.5 $53,872 - $70,035	1,218 Added 15.54%	9,055 $446,000
Q4 2020 Feb 16, 2021	BUY	$33.21 - $46.54 $23,114 - $32,391	696 Added 9.75%	7,837 $349,000
Q3 2020 Nov 16, 2020	BUY	$33.87 - $55.93 $12,023 - $19,855	355 Added 5.23%	7,141 $246,000
Q2 2020 Aug 14, 2020	BUY	$34.45 - $53.48 $93,359 - $144,930	2,710 Added 66.49%	6,786 $360,000
Q1 2020 May 14, 2020	BUY	$31.52 - $53.81 $13,112 - $22,384	416 Added 11.37%	4,076 $144,000
Q4 2019 Feb 14, 2020	BUY	$30.08 - $50.59 $25,237 - $42,445	839 Added 29.74%	3,660 $176,000
Q3 2019 Nov 14, 2019	SELL	$32.4 - $49.58 $972 - $1,487	-30 Reduced 1.05%	2,821 $97,000
Q2 2019 Aug 14, 2019	BUY	$46.17 - $68.1 $50,879 - $75,046	1,102 Added 63.01%	2,851 $142,000
Q1 2019 May 07, 2019	BUY	$45.92 - $67.67 $7,209 - $10,624	157 Added 9.86%	1,749 $118,000
Q4 2018 Feb 01, 2019	BUY	$42.73 - $76.53 $9,229 - $16,530	216 Added 15.7%	1,592 $73,000
Q3 2018 Nov 14, 2018	BUY	$71.67 - $91.95 $10,320 - $13,240	144 Added 11.69%	1,376 $106,000
Q2 2018 Aug 14, 2018	BUY	$73.22 - $99.55 $2,123 - $2,886	29 Added 2.41%	1,232 $642,000
Q1 2018 May 15, 2018	BUY	$59.83 - $86.53 $8,974 - $12,979	150 Added 14.25%	1,203 $89,000
Q4 2017 Feb 14, 2018	BUY	$52.12 - $72.33 $7,818 - $10,849	150 Added 16.61%	1,053 $63,000
Q3 2017 Nov 14, 2017	BUY	$54.89 - $67.12 $49,565 - $60,609	903	903 $60,000

Others Institutions Holding AGIO

# of Institutions

232

Shares Held

58.1M

Call Options Held

403K

Put Options Held

469K

View Full List

About AGIOS PHARMACEUTICALS, INC.

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $1.87B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

More about AGIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of ETF Managers Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on ETF Managers Group, LLC with notifications on news.

Account

ETF Managers Group, LLC Agios Pharmaceuticals, Inc. Transaction History